Most sold healthcare stocks
Discover which Healthcare stocks institutional investors trimmed or exited the most, measured as net reductions in reported share positions from Q4 2025 into Q1 2026. Notable reductions at the top of this list include STANDARD BIOTOOLS INC (LAB), DAVITA INC (DVA), ADAPTIVE BIOTECHNOLOGIES (ADPT), UNITEDHEALTH GROUP INC (UNH). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| LAB | STANDARD BIOTOOLS INC | -58,651,170 | -$75.07M | 0 | 0 | 0 | 1 | 0 |
| DVA | DAVITA INC | -31,927,938 | -$3.63B | 1 | 0 | 0 | 2 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | -30,319,475 | -$492.39M | 0 | 0 | 0 | 2 | 0 |
| UNH | UNITEDHEALTH GROUP INC | -15,217,477 | -$4.68B | 1 | 2 | 1 | 12 | 4 |
| NVST | ENVISTA HOLDINGS CORP | -14,531,819 | -$309.57M | 1 | 0 | 1 | 3 | 2 |
| BBIO | BRIDGEBIO PHARMA INC | -14,432,175 | -$1.10B | 0 | 0 | 0 | 2 | 0 |
| EXEL | EXELIXIS INC | -13,901,339 | -$609.31M | 1 | 0 | 0 | 1 | 1 |
| PRVA | PRIVIA HEALTH GROUP INC | -12,601,843 | -$298.79M | 0 | 0 | 0 | 2 | 0 |
| ZTS | ZOETIS INC | -10,198,246 | -$1.28B | 1 | 0 | 0 | 5 | 1 |
| OPCH | OPTION CARE HEALTH INC | -9,475,080 | -$301.88M | 0 | 0 | 0 | 2 | 0 |
| BSX | BOSTON SCIENTIFIC CORP | -9,075,708 | -$866.94M | 1 | 0 | 0 | 5 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | -8,895,430 | -$193.83M | 0 | 0 | 0 | 2 | 0 |
| SGMO | SANGAMO THERAPEUTICS INC | -8,430,323 | -$3.54M | 0 | 0 | 0 | 1 | 0 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | -8,204,973 | -$27.65M | 0 | 0 | 0 | 1 | 0 |
| RDY | DR. REDDY'S LABORATORIES-ADR | -8,092,068 | -$113.64M | 1 | 0 | 0 | 1 | 1 |
| TDOC | TELADOC HEALTH INC | -7,978,142 | -$55.85M | 0 | 0 | 0 | 1 | 0 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -7,276,246 | -$432.68M | 2 | 0 | 0 | 2 | 2 |
| DHR | DANAHER CORP | -7,179,796 | -$1.64B | 2 | 0 | 1 | 5 | 3 |
| ORIC | ORIC PHARMACEUTICALS INC | -7,145,415 | -$58.45M | 0 | 0 | 0 | 2 | 0 |
| SDGR | SCHRODINGER INC | -6,981,664 | -$124.83M | 0 | 0 | 0 | 1 | 0 |
| XRAY | DENTSPLY SIRONA INC | -6,896,209 | -$78.82M | 1 | 0 | 0 | 2 | 1 |
| BLCO | BAUSCH + LOMB CORP | -6,882,739 | -$117.56M | 0 | 0 | 0 | 2 | 0 |
| BAYRY | BAYER AG-SPONSORED ADR | -6,754,291 | -$73.08M | 0 | 0 | 0 | 1 | 0 |
| ABT | ABBOTT LABORATORIES | -6,738,774 | -$852.59M | 1 | 0 | 1 | 4 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | -6,564,052 | -$70.83M | 0 | 0 | 0 | 2 | 0 |
| CPRX | CATALYST PHARMACEUTICALS INC | -6,013,884 | -$140.36M | 0 | 0 | 0 | 2 | 0 |
| CORT | CORCEPT THERAPEUTICS INC | -5,758,528 | -$200.40M | 0 | 0 | 0 | 1 | 0 |
| CVS | CVS HEALTH CORP | -5,313,548 | -$525.55M | 1 | 0 | 3 | 4 | 5 |
| RLYB | RALLYBIO CORP | -5,030,469 | -$3.45M | 0 | 0 | 0 | 2 | 0 |
| TECH | BIO-TECHNE CORP | -4,848,757 | -$285.21M | 1 | 0 | 0 | 2 | 1 |
| SYK | STRYKER CORP | -4,815,135 | -$1.69B | 1 | 0 | 1 | 4 | 2 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | -4,491,141 | -$10.55M | 0 | 0 | 0 | 1 | 0 |
| ELV | ELEVANCE HEALTH INC | -4,398,460 | -$994.55M | 1 | 2 | 0 | 5 | 3 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | -4,225,089 | -$13.73M | 0 | 0 | 0 | 1 | 0 |
| INVA | INNOVIVA INC | -4,200,520 | -$83.94M | 1 | 0 | 0 | 1 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -4,190,726 | -$258.55M | 1 | 0 | 0 | 2 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -4,144,090 | -$211.50M | 2 | 0 | 0 | 3 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | -4,121,727 | -$106.48M | 1 | 0 | 1 | 7 | 2 |
| DOCS | DOXIMITY INC-CLASS A | -4,015,451 | -$177.80M | 0 | 0 | 0 | 2 | 0 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -3,987,749 | -$7.46M | 0 | 0 | 0 | 2 | 0 |
| WEAV | WEAVE COMMUNICATIONS INC | -3,979,749 | -$30.28M | 1 | 0 | 0 | 2 | 1 |
| INCY | INCYTE CORP | -3,961,955 | -$391.40M | 1 | 0 | 0 | 1 | 1 |
| MDXG | MIMEDX GROUP INC | -3,949,959 | -$26.74M | 0 | 0 | 0 | 2 | 0 |
| NUVB | NUVATION BIO INC | -3,811,513 | -$34.15M | 0 | 0 | 0 | 1 | 0 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | -3,741,499 | -$837.95M | 2 | 0 | 1 | 4 | 3 |
| ADMA | ADMA BIOLOGICS INC | -3,634,675 | -$66.30M | 0 | 0 | 0 | 2 | 0 |
| PEPG | PEPGEN INC | -3,630,334 | -$23.63M | 0 | 0 | 0 | 2 | 0 |
| OGN | ORGANON & CO | -3,629,451 | -$26.02M | 0 | 0 | 0 | 1 | 0 |
| AKBA | AKEBIA THERAPEUTICS INC | -3,593,133 | -$5.78M | 0 | 0 | 0 | 1 | 0 |
| WAT | WATERS CORP | -3,567,499 | -$1.36B | 2 | 0 | 0 | 2 | 2 |
Frequently asked questions about Most sold healthcare stocks
What are the most sold Healthcare stocks in Q1 2026?
The most sold healthcare stocks in Q1 2026 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q4 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2026?
Among the managers we track, net reductions were largest in companies such as STANDARD BIOTOOLS INC (LAB), DAVITA INC (DVA), ADAPTIVE BIOTECHNOLOGIES (ADPT), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q4 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.